One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: A prospective randomized study

Journal of Thoracic and Cardiovascular Surgery

Volumn 141, Issue 4, 2011, Pages 995-1001

  Braathen, Bjørn ^a   Jeppsson, Anders ^b,c   Scherstén, Henrik ^b,c   Hagen, Ole M ^a   Vengen, Øystein ^a   Rexius, Helena ^b,c   Lepore, Vincenzo ^b,c   Tønnessen, Theis ^a,d  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPLEGIC AGENT; CREATINE KINASE MB; HTK SOLUTION; INOTROPIC AGENT; TROPONIN T;

ADULT; ARTICLE; BODY SURFACE; CARDIOPLEGIA; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MITRAL VALVE REGURGITATION; ORGAN PRESERVATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CARDIOPLEGIC SOLUTIONS; CHI-SQUARE DISTRIBUTION; CREATINE KINASE, MB FORM; FEMALE; GLUCOSE; HEART ARREST, INDUCED; HUMANS; HYPOTHERMIA, INDUCED; LINEAR MODELS; MALE; MANNITOL; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL INFARCTION; NORWAY; POTASSIUM CHLORIDE; PROCAINE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T;

EID: 79952993620     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.07.011     Document Type: Article

References (27)

1. R.C. Gallandat Huet, G.F. Karliczek, J.N. van der Heide, U. Brenken, B. Mooi, and J.J. van der Broeke Clinical effect of Bretschneider-HTK and St. Thomas cardioplegia on hemodynamic performance after bypass measured using an automatic datalogging database system Thorac Cardiovasc Surg 36 1988 151 156
2. J.P. Remadi, O. Baron, C. Roussel, P. Bizouarn, A. Habasch, and P. Despins Isolated mitral valve replacement with St Jude Medical prosthesis: long-term results: a follow-up of 19 years Circulation 103 2001 1542 1545 (Pubitemid 32226262)
3. U. Mehlhorn, H. Sauer, F. Kuhn-Regnier, M. Sudkamp, S. Dhein, and F. Eberhardt Myocardial beta-blockade as an alternative to cardioplegic arrest during coronary artery surgery Cardiovasc Surg 7 1999 549 557 (Pubitemid 29349672)
4. L. Salvador, S. Mirone, R. Bianchini, T. Regesta, F. Patelli, and G. Minniti A 20-year experience with mitral valve repair with artificial chordae in 608 patients J Thorac Cardiovasc Surg 135 2008 1280 1287
5. M.M. Gebhard, C.J. Preusse, P.A. Schnabel, and H.J. Bretschneider Different effects of cardioplegic solution HTK during single or intermittent administration Thorac Cardiovasc Surg 32 1984 271 276 (Pubitemid 14018415)
6. J. Liu, Z. Feng, J. Zhao, B. Li, and C. Long The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery ASAIO J 54 2008 470 473
7. B.S. Allen, J.W. Winkelmann, H. Hanafy, R.S. Hartz, K.S. Bolling, and J. Ham Retrograde cardioplegia does not adequately perfuse the right ventricle J Thorac Cardiovasc Surg 109 1995 1116 1124
8. B. Braathen, and T. Tønnessen Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve replacement for isolated aortic stenosis J Thorac Cardiovasc Surg 139 2010 874 880
9. J.L. Januzzi, K. Lewandrowski, T.E. MacGillivray, J.B. Newell, S. Kathiresan, and S.J. Servoss A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery J Am Coll Cardiol 39 2002 1518 1523 (Pubitemid 34439070)
10. A.C. Larstorp, S.C. Lund, T. Tønnessen, C. Muller, S.E. Kjeldsen, and A. Mangschau Scintigraphic demonstration of myocardial perfusion and ischaemia associated with coronary artery bypass grafting Scand Cardiovasc J 40 2006 354 362 (Pubitemid 44803888)
11. B. Braathen, O.A. Vengen, and T. Tønnessen Myocardial cooling with ice-slush provides no cardioprotective effects in aortic valve replacement Scand Cardiovasc J 40 2006 368 373 (Pubitemid 44803890)
12. E. Aarsæther, T.A. Stenberg, O. Jakobsen, and R. Busund Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia - an experimental comparative study in pigs Interact Cardiovasc Thorac Surg 9 2009 635 639
13. H.J. Bretschneider Myocardial protection Thorac Cardiovasc Surg 28 1980 295 302 (Pubitemid 10025665)
14. C.J. Preusse, J. Winter, H.D. Schulte, and W. Bircks Energy demand of cardioplegically perfused human hearts J Cardiovasc Surg (Torino) 26 1985 558 563 (Pubitemid 16254330)
15. C.J. Preusse, M.M. Gebhard, and H.J. Bretschneider Myocardial "equilibration processes" and myocardial energy turnover during initiation of artificial cardiac arrest with cardioplegic solution - reasons for a sufficiently long cardioplegic perfusion Thorac Cardiovasc Surg 29 1981 71 76 (Pubitemid 11147820)
16. J.A. Fridell, R.S. Mangus, and A.J. Tector Clinical experience with histidine-tryptophan-ketoglutarate solution in abdominal organ preservation: a review of recent literature Clin Transplant 23 2009 305 312
17. F. Beyersdorf, E. Krause, K. Sarai, B. Sieber, N. Deutschlander, and G. Zimmer Clinical evaluation of hypothermic ventricular fibrillation, multi-dose blood cardioplegia, and single-dose Bretschneider cardioplegia in coronary surgery Thorac Cardiovasc Surg 38 1990 20 29 (Pubitemid 20050353)
18. T. Fanneløp, G.O. Dahle, P.R. Salminen, C.A. Moen, K. Matre, and A. Mongstad Multidose cold oxygenated blood is superior to a single dose of Bretschneider HTK-cardioplegia in the pig Ann Thorac Surg 87 2009 1205 1213
19. J. Sakata, K. Morishita, T. Ito, T. Koshino, T. Kazui, and T. Abe Comparison of clinical outcome between histidine-triptophan-ketoglutalate solution and cold blood cardioplegic solution in mitral valve replacement J Card Surg 13 1998 43 47 (Pubitemid 29030744)
20. C. Savini, N. Camurri, A. Castelli, A. Dell'Amore, D. Pacini, and S.M. Suarez Myocardial protection using HTK solution in minimally invasive mitral valve surgery Heart Surg Forum 8 2005 E25 E27
21. A. Arslan, A. Sezgin, B. Gultekin, S. Ozkan, T. Akay, and E. Uguz Low-dose histidine-tryptophan-ketoglutarate solution for myocardial protection Transplant Proc 37 2005 3219 3222 (Pubitemid 41435665)
22. G. Careaga, D. Salazar, S. Tellez, O. Sanchez, G. Borrayo, and R. Arguero Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients Arch Med Res 32 2001 296 299 (Pubitemid 32611642)
23. A.S. Manning, and D.J. Hearse Reperfusion-induced arrhythmias: mechanisms and prevention J Mol Cell Cardiol 16 1984 497 518 (Pubitemid 15040732)
24. W.L. Holman, R.D. Spruell, W.V. Vicente, and A.D. Pacifico Electrophysiological mechanisms for postcardioplegia reperfusion ventricular fibrillation Circulation 90 5 Pt 2 1994 II293 II298
25. G. Gorlach, T. Podzuweit, B. Borsutzky, E. Lohmann, and F. Dapper Factors determining ventricular fibrillation after induced cardiac arrest Thorac Cardiovasc Surg 39 1991 140 142
26. C.P. Murrah, E.R. Ferguson, R.D. Spruell, and W.L. Holman Arrest duration influences postcardioplegia electrophysiologic recovery and reperfusion arrhythmias Ann Thorac Surg 65 1998 1003 1008
27. O.F. Sellevold, E.M. Berg, and O.W. Levang Procaine is effective for minimizing postischemic ventricular fibrillation in cardiac surgery Anesth Analg 81 1995 932 938